Download presentation
Presentation is loading. Please wait.
Published by광현 영 Modified over 5 years ago
1
Carfilzomib, Cyclophosphamide and Dexamethasone (KCD) Versus Bortezomib, Cyclophosphamide and Dexamethasone (VCD) for Treatment of First Relapse or Primary Refractory Multiple Myeloma (MM): First Final Analysis of the Phase 2 Muk Five Study by Kwee Yong, Samantha Hinsley, Holger W. Auner, Debbie Sherratt, Ruth Mary De Tute, Sarah Brown, Louise Flanagan, Cathy Williams, Jamie Cavenagh, Martin F Kaiser, Neil Rabin, Karthik Ramasamy, Mamta Garg, Stephen F. Hawkins, Ceri Bygrave, Gareth J. Morgan, Faith E. Davies, and Roger G Owen Blood Volume 130(Suppl 1): December 7, 2017 ©2017 by American Society of Hematology
2
Kwee Yong et al. Blood 2017;130:835 ©2017 by American Society of Hematology
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.